Low IGFBP7 rate had a significantly reduced survival, poor differentiation, and a higher tumor stage; in all examined breast cancer cases, 15% lacked IGFBP7 staining entirely, but 20% had weak staining, 32% intermediate and 33%, finally, showed strong staining (83). This evidence concerns the gene IGFBP7 and breast cancer.